Skip to main content

Tweets

News Feature: Unique Oral Microbiome in Early and Pre-Clinical RA An oral microbiome study of rheumatoid arthritis (RA) patients suggests that periodontal condition in patients with early rheumatoid arthritis (ERA) and individuals at risk of RA. https://t.co/r3kT52MByC https://t.co/MocZ6PXZzA
Dr. John Cush @RheumNow ( View Tweet )
3 days 18 hours ago
Have you listened to the latest RheumNow podcast? Falling or Falling in Love https://t.co/SmPCqKpXLY https://t.co/LQSsGJCY9u
Dr. John Cush @RheumNow ( View Tweet )
3 days 21 hours ago
News Feature: Avacopan for ANCA Vasculitis Goes in Front of the FDA An FDA advisory panel will consider whether to recommend approval of an oral C5a inhibitor for ANCA-associated vasculitis. https://t.co/66NSjbkE8Q https://t.co/9cR2lBASjz
Dr. John Cush @RheumNow ( View Tweet )
4 days ago
#LupusAwarenessMonth Dr. Kathryn Dao - Risk of Hydroxychloroquine Retinal Toxicity From ACR 2020 https://t.co/7BCVvMOm0T https://t.co/PhHubO7rxG
Dr. John Cush @RheumNow ( View Tweet )
4 days 19 hours ago
News Feature: ARTIC REWIND - Don't Half DMARD Therapy https://t.co/mZFehDM9nf https://t.co/QQ8IhMYUjk
Dr. John Cush @RheumNow ( View Tweet )
5 days 1 hour ago
#LupusAwarenessMonth Dr. Janet Pope - Belimumab in SLE nephritis From ACR 2020 https://t.co/ZoMslbX5dF https://t.co/xnKXXRJ6wE
Dr. John Cush @RheumNow ( View Tweet )
5 days 15 hours ago
#LupusAwarenessMonth Dr. Michelle Petri - Best Practices in Testing for Antiphospholipid Syndrome (LAC wins) From ACR 2020 https://t.co/IyeRDzw4BC https://t.co/nSkauHf29T
Dr. John Cush @RheumNow ( View Tweet )
5 days 18 hours ago
New podcast alert! Falling or Falling in Love (5.7.2021) Dr Jack Cush reviews the best journal articles of the week from RheumNow https://t.co/HyAPN2rM3L https://t.co/C5XtqthO8I
Dr. John Cush @RheumNow ( View Tweet )
5 days 21 hours ago
May is also arthritis awareness month! Why we love Rheumatology Fellows https://t.co/rNVjZZr9l4 #ArthritisAwarenessMonth

Dr. John Cush @RheumNow ( View Tweet )

5 days 22 hours ago
News Feature: Drug Monitoring Ineffective with Infliximab Treatment A randomized trial compared TDM to no TDM in patients receiving infliximab for chronic IMIDs and found that TDM did not increase the odds of achieving remission. https://t.co/AVcX4EXY0l https://t.co/RlDij6ln61
Dr. John Cush @RheumNow ( View Tweet )
6 days ago
Falls are not uncommon in #RA patients; significant risk factors for falls include being elderly, un-married, higher pain scores, reported dizziness taking psychotropic medications and having lower HRQoL scores https://t.co/a8qA7n68q5

Dr. John Cush @RheumNow ( View Tweet )

6 days 3 hours ago
Today begins National Nurses week! God Bless Rheumatology Nurses https://t.co/JC9ExqnXEb #ArthritisAwarenessMonth https://t.co/bhuocIlHWT
Dr. John Cush @RheumNow ( View Tweet )
6 days 15 hours ago
×